Today is March 4, 2026, and the baseball world is buzzing with news that has left many fans and players alike in disbelief. Jurickson Profar, the Atlanta Braves’ outfielder, has been handed a hefty 162-game suspension by Major League Baseball (MLB) due to a second positive test for performance-enhancing drugs. This marks a significant setback for the 33-year-old player who joined the Braves in 2025.
Profar’s recent troubles stem from testing positive for exogenous testosterone and its metabolites, leading to a loss of his entire 2026 season. The financial implications are staggering, as he will forfeit his $15 million salary from a three-year contract worth $42 million that extends through 2027. This isn’t Profar’s first brush with the law; he was previously suspended for 80 games in March 2024 after testing positive for Chorionic Gonadotrophin (hCG), a hormone that boosts testosterone production. That initial suspension cost him half of his $12 million salary for that year.
Braves React and Future Implications
The Atlanta Braves expressed their disappointment over Profar’s failed drug test, emphasizing their commitment to MLB’s Drug Prevention and Treatment Program. Profar’s absence will create a void in the roster, especially since he was expected to be a key player for the team as their primary designated hitter following the signing of Mike Yastrzemski.
With Profar sidelined, the Braves will need to strategize effectively. Other outfield options include Michael Harris and Ronald Acuña Jr., while Eli White may step in as a potential designated hitter. Additionally, the team might look to Dominic Smith, who recently signed a minor league deal, to fill the gap left by Profar. This restructuring comes at a crucial time, especially with projected starting shortstop Ha-seong Kim currently injured, leaving Mauricio Dubon as the expected starter.
Legal Actions and Historical Context
In a twist, Profar plans to appeal the suspension, with the players’ association filing a grievance on his behalf to independent arbitrator Martin F. Scheinman. The appeal process is a critical step, especially considering Profar’s previous assertions that he would never knowingly take a banned substance. This situation is not unique to him; he is the seventh player to receive a 162-game suspension for a second doping offense, joining a list that includes notable names like Robinson Canó and Jenrry Mejia, the latter of whom received a lifetime ban after a third positive test.
Profar’s case highlights a persistent issue in professional sports. Doping scandals are not new, and they continue to rear their ugly heads across various sports. In 2024 alone, there were over 12,100 doping tests conducted in Germany, with a significant number of violations still going unnoticed. Despite regular screenings, athletes often resort to performance-enhancing substances to gain an edge, underscoring the ongoing battle against doping in sports.
As we look towards the rest of the baseball season, the fallout from Profar’s suspension will undoubtedly be felt, not just by the Braves but throughout the league. For more details on this unfolding story, you can check the full report at Welt.de and further insights from AP News.